Bill > SR62

This Senate Resolution (SR 62) recognizes the serious challenges posed by pancreatic cancer in California and nationwide, highlighting critical statistics about the disease's impact. The resolution notes that in 2025, an estimated 67,440 people will be diagnosed with pancreatic cancer, with 51,980 expected to die, making it the third leading cause of cancer death with a devastating five-year survival rate of only 13 percent. The document points out that pancreatic cancer research receives disproportionately low funding from the National Cancer Institute (NCI), which allocated only $226,800,000 (3.3 percent of its budget) to pancreatic cancer research in 2022. The Senate formally proclaims November 2025 as Pancreatic Cancer Awareness Month in California, urging residents to "wage hope to end pancreatic cancer" and recognizing the importance of developing early detection and treatment tools. The resolution also acknowledges the Pancreatic Cancer Action Network (PanCAN), a national organization headquartered in California that is investing $126,000,000 in research and received $15,000,000 in congressional funding. Finally, the resolution directs the Secretary of the Senate to distribute copies of the document for appropriate awareness and action.

https://leginfo.legislature.ca.gov/faces/billStatusClient.xhtml?bill_id=202520260SR62